Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Preoperative evaluation of risk of ovarian malignancy algorithm index in prediction of malignancy of adnexal masses.

Farzaneh F, Honarvar Z, Yaraghi M, Yaseri M, Arab M, Hosseini M, Ashrafgangoi T.

Iran Red Crescent Med J. 2014 Jun;16(6):e17185. doi: 10.5812/ircmj.17185. Epub 2014 Jun 5.

PMID:
25068046
[PubMed]
Free PMC Article
2.

Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysis.

Zhen S, Bian LH, Chang LL, Gao X.

Mol Clin Oncol. 2014 Jul;2(4):559-566. Epub 2014 Apr 16.

PMID:
24940495
[PubMed]
Free PMC Article
3.

Ovarian cancer symptom awareness and anticipated delayed presentation in a population sample.

Brain KE, Smits S, Simon AE, Forbes LJ, Roberts C, Robbé IJ, Steward J, White C, Neal RD, Hanson J; ICBP Module 2 Working Group.

BMC Cancer. 2014 Mar 10;14:171. doi: 10.1186/1471-2407-14-171.

PMID:
24612526
[PubMed - in process]
Free PMC Article
4.

Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses.

Pitta Dda R, Sarian LO, Barreta A, Campos EA, Andrade LL, Fachini AM, Campbell LM, Derchain S.

BMC Cancer. 2013 Sep 18;13:423. doi: 10.1186/1471-2407-13-423.

PMID:
24044637
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Diagnosis and preoperative predictive value of serum HE4 concentrations for optimal debulking in epithelial ovarian cancer.

Yang Z, Luo Z, Zhao B, Zhang W, Zhang J, Li Z, Li L.

Oncol Lett. 2013 Jul;6(1):28-34. Epub 2013 May 8.

PMID:
23946773
[PubMed]
Free PMC Article
6.

The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomas.

Simmons AR, Baggerly K, Bast RC Jr.

Oncology (Williston Park). 2013 Jun;27(6):548-56. Review.

PMID:
23909069
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysis.

Yang Z, Wei C, Luo Z, Li L.

Onco Targets Ther. 2013 Jul 23;6:957-66. doi: 10.2147/OTT.S45681. Print 2013. Erratum in: Onco Targets Ther. 2014;7:135.

PMID:
23901285
[PubMed]
Free PMC Article
8.

The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors.

Lawicki S, Będkowska GE, Gacuta-Szumarska E, Szmitkowski M.

J Ovarian Res. 2013 Jul 2;6(1):45. doi: 10.1186/1757-2215-6-45.

PMID:
23819707
[PubMed]
Free PMC Article
9.

Biomarker testing for ovarian cancer: clinical utility of multiplex assays.

Nolen BM, Lokshin AE.

Mol Diagn Ther. 2013 Jun;17(3):139-46. doi: 10.1007/s40291-013-0027-6. Review.

PMID:
23552992
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancer.

Urban N, Thorpe J, Karlan BY, McIntosh MW, Palomares MR, Daly MB, Paley P, Drescher CW.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2087-94. doi: 10.1158/1055-9965.EPI-12-0616. Epub 2012 Sep 7.

PMID:
22962406
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

High preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancer.

Kalapotharakos G, Asciutto C, Henic E, Casslén B, Borgfeldt C.

J Ovarian Res. 2012 Aug 21;5(1):20. doi: 10.1186/1757-2215-5-20.

PMID:
22909379
[PubMed]
Free PMC Article
12.

Diagnosis and management of peritoneal metastases from ovarian cancer.

Halkia E, Spiliotis J, Sugarbaker P.

Gastroenterol Res Pract. 2012;2012:541842. doi: 10.1155/2012/541842. Epub 2012 Jul 19.

PMID:
22888339
[PubMed]
Free PMC Article
13.

HE4, CA-125, and cystic ovarian mass.

Wiwanitkit V.

J Gynecol Oncol. 2012 Apr;23(2):133. doi: 10.3802/jgo.2012.23.2.133A. Epub 2012 Apr 3. No abstract available.

PMID:
22523632
[PubMed]
Free PMC Article
14.
15.

Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass.

Partheen K, Kristjansdottir B, Sundfeldt K.

J Gynecol Oncol. 2011 Dec;22(4):244-52. doi: 10.3802/jgo.2011.22.4.244. Epub 2011 Dec 5.

PMID:
22247801
[PubMed]
Free PMC Article
16.

Designing early detection programs for ovarian cancer.

Urban N.

Ann Oncol. 2011 Dec;22 Suppl 8:viii6-viii18. doi: 10.1093/annonc/mdr472.

PMID:
22180403
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Protein biomarkers of ovarian cancer: the forest and the trees.

Nolen BM, Lokshin AE.

Future Oncol. 2012 Jan;8(1):55-71. doi: 10.2217/fon.11.135. Review.

PMID:
22149035
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptability.

Goff BA, Lowe KA, Kane JC, Robertson MD, Gaul MA, Andersen MR.

Gynecol Oncol. 2012 Feb;124(2):230-5. doi: 10.1016/j.ygyno.2011.10.032. Epub 2011 Nov 6.

PMID:
22063459
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management.

Bandiera E, Romani C, Specchia C, Zanotti L, Galli C, Ruggeri G, Tognon G, Bignotti E, Tassi RA, Odicino F, Caimi L, Sartori E, Santin AD, Pecorelli S, Ravaggi A.

Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2496-506. doi: 10.1158/1055-9965.EPI-11-0635. Epub 2011 Oct 25.

PMID:
22028406
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Ovarian Cancer Tests and Treatment.

Carter JS, Downs LS Jr.

Female Patient (Parsippany). 2011;36(4):30-35.

PMID:
21841893
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk